ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
Summary of the Group
Scientists can now connect company-approved AI providers such as Claude Code and GitHub Copilot directly to Flare, helping teams set up, execute, and analyze complex computational chemistry workflows in minutes not hours.
Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.
What do we mean by ‘Projectification’? Projectification refers to the increasing trend of organizing work and resources around specific projects rather than traditional functional structures. It refers to the redesign of culture, systems, structures, people practices, rewards, measures - in order that an organisation becomes more fit for purpose for the future. Come along to learn more, share your views and find out what it will all mean for you.
LONDON, UK; HELSINKI, FINLAND; and NAPLES, ITALY – October 6, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Valo Therapeutics Group ("Valo Therapeutics") and is pleased to announce the placement of Carlos de Sousa, M.D., MBA, as Chief Executive Officer.
Cancer Research UK have signed an agreement with ORIC Pharmaceuticals, Inc. to advance ORIC-259, a potential first-in-class CIP2A-targeted therapy, into clinical development.

Showcasing Cambridge & London life science, biotech, deeptech & techbio ventures, offering investors early insight, and emerging innovation.